• SuperCom, a global leading provider of digital identity and tracking solutions, is highlighting its electronic monitoring solutions for domestic violence and stalking prevention, with January marking the twentieth annual National Stalking Awareness Month
• In 2023 alone, over 3 million people aged 16 and older were victims of stalking
• Stalking has uprooted people’s lives, causing them to leave their jobs, suffer physical and psychological harm, or even lose their life

SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity and tracking solutions to governments, is highlighting its electronic monitoring (“EM”) solutions used for monitoring offenders and domestic violence prevention. These solutions have proven effective in lowering subsequent tracking offenses and protecting victims. It comes in the wake of the ongoing conversation on stalking, coupled with the growing cases of stalking victims, even as this month of January marks the twentieth annual National Stalking Awareness Month (“NSAM”) (https://ibn.fm/sevvH).

January is dedicated to recognizing, taking action, and responding to the severe crime of stalking, which in 2023 affected over 3 million people aged 16 and older in the U.S. alone (https://ibn.fm/T7J7y). This cuts across stalking in person and online and has forced people to uproot their lives, leave their jobs, suffer physical and psychological harm, or even lose lives. According to Olivia Duffy, a victim advocate at Naval Station Mayport, stalking can show up in many forms, including tracking a person’s location, unwanted communication, harassing an individual, property damage, physically following a person, spreading rumors, or even posting or sharing threats (https://ibn.fm/ThofM).

In recent months, there have been cases of victims killed by their stalkers, including those working in the military, as was the case with Brittney Mitchell, who was shot and killed by her husband. The latter was abusive, and Mitchell resorted to divorcing him. She even filed for a restraining order but was still stalked and killed by her husband. It is but one of the many such terrible instances. Unfortunately, many victims never get justice since, according to Duffy, “You really have to have an offender that has to almost be caught in the process.”

SuperCom understands these challenges and seeks to address them using its EM solutions. Its proprietary electronic monitoring technology has proven to enable customers and criminal justice agencies to detect unauthorized movements of people, vehicles, and other monitored objects, ultimately guaranteeing the safety of stalking victims and holding offenders accountable. The company’s monitoring solutions support various programs such as:

• GPS Monitoring 
• House Arrest
• Domestic Violence Prevention
• Inmate Monitoring
• Alcohol Monitoring
• Rehabilitation Services

SuperCom’s solutions have been tried and proven in the field, with various governments around the world adopting them, displaying their effectiveness and functionality. In 2023, the government of Finland also adopted SuperCom’s solutions for its domestic violence monitoring program with an aim to safeguard victims and proactively prevent domestic violence (https://ibn.fm/CvrqC). In the U.S., the company recently secured a new contract with a prominent Kentucky-based service provider, aiding in the company’s expansion into this lucrative market (https://ibn.fm/quCYC).

As the company continues to push for its products, it is carving out a greater market share in the growing electronics monitoring solutions market. This market is expected to post a CAGR of 10.8% between 2021 and 2026. It also expects to tap into the global cybersecurity market, projected to grow from $173.5 billion in 2022 to $266.2 billion by 2027. Most importantly, it looks to protect the millions of domestic violence and stalking victims worldwide and hold offenders accountable.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• An internationally recognized expert on security issues, Secretary Nielsen brings a depth of knowledge and expertise on policy, strategy and operations
• She is steeped in emerging technologies, including artificial intelligence (“AI”) and quantum, and has advised technology companies of all sizes
• Her appointment to the company’s board of directors highlights governments’ rapidly accelerating interest and investment in today’s quantum technology

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the addition of Kirstjen Nielsen, former Secretary of the U.S. Department of Homeland Security, to the company’s board of directors. This board appointment highlights governments’ rapidly accelerating interest and investment in today’s quantum technology (https://ibn.fm/Wx95O). D-Wave is continuing to drive increasing enterprise and government adoption of quantum technology.

Secretary Nielsen is internationally recognized and a proven leader on security issues critical to the United States of America’s highest priorities, including enterprise risk, resiliency, cybersecurity, and emerging threats. She has in-depth knowledge of emerging technology policy, including AI and quantum, and has advised technology companies, from startups to Fortune 100 corporations.

Secretary Nielsen said quantum computing has the potential to transform the way governments and businesses tackle operational complexities, and she believes that D-Wave is leading this evolution. “From the amazing technology developments on the horizon to the impressive scientific results I’ve seen, D-Wave is well-positioned to capitalize on its unique strengths as it ushers in this new era of computing,” Nielsen added. “I’m looking forward to helping the company during this pivotal time.”

Secretary Nielsen’s experience includes policy, strategy, and operations, giving her a unique perspective and influencing her position on the importance of stakeholder engagement. Her history of working with governments to utilize emerging technologies as a force multiplier is important for today’s quantum computing, as it has advanced to tackling real-world problems. D-Wave’s expertise in this area is showcased in its Customer Success Stories (https://ibn.fm/7Pw2a).

D-Wave customers include blue-chip industry leaders like Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin. D-Wave also owns one of the industry’s largest quantum computer intellectual property portfolios, with more than 210 issued U.S. patents.

Beyond her work with the Department of Homeland Security, Secretary Nielsen has held various domestic and international government roles. She has served on the White House Homeland Security Council, helped create and run the TSA, and led the World Economic Forum’s Global Agenda Council on Risk and Resilience. Secretary Nielsen is a member of the State Bar of Texas, holds a B.S. in foreign service from Georgetown University and a J.D. from the University of Virginia’s School of Law, and has practiced transactional law.

D-Wave CEO Dr. Alan Baratz said this is a transformative time in quantum computing, as governments and businesses increasingly recognize the near-term value today’s quantum solutions can deliver. “It’s also a transformative time for D-Wave, and we’re incredibly excited to have Secretary Nielsen join the board to help the company accelerate quantum adoption and explore quantum’s impact on AI and machine learning. As an attorney, public servant, and US and international policy expert, she will bring valuable perspectives to the D-Wave board,” Baratz added.

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding the potential of quantum computing, D-Wave’s positioning in the industry, and the perspectives that Sec. Nielsen will bring to the D-Wave board. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risk that Sec. Nielsen may leave the D-Wave board sooner than expected; general economic conditions and other risks; the company’s ability to expand its customer base and the customer adoption of its solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against the company; risks related to the performance of the company’s business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of D-Wave’s products; the effects of competition on the company’s business; the risk that D-Wave will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the company may never achieve or sustain profitability; the risk that that company is unable to secure or protect its intellectual property; volatility in the price of its securities; the risk that its securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to the company on the date hereof. D-Wave undertakes no duty to update this information unless required by law.

Finovate is Europe’s leading fintech conference that offers a phenomenal platform for companies and executives. They come together at Finovate to discover and discuss innovative ideas and develop impactful connections in various fintech verticals. Get important insights as experts delve deep into vital and trending topics of the fast developing fintech world.

At Finovate, you see the best operational strategies from financial influencers. Fintech firms and entrepreneurs must leverage this huge opportunity to develop networking ties with investors, bankers, and key financial innovators.

Attendees get immense exposure as over 1,000 decision-makers with 100+ expert speakers and 500+ financial institutions will be a part of this two-day conference. Representatives from banks and financial institutions include giant firms such as Lloyds Banking Group, Citi, BNP Paribas, Bank of America, HSBC, Barclays, JP Morgan Asset Management, Commerzbank, and more.

Around 35 startups, upcoming firms as well as established firms across Europe, will provide 7-minute demos highlighting their financial services and the newest tech ideas. Avoiding slides and videos, they will offer a quick informative vision, an efficient way to be introduced to the latest offerings.

The lineup of demo sessions includes players from the fintech spectrum across retail banking, sustainability, business banking, wealth management, and more. 89% of the companies will showcase demos at Finovate for the first time. 71% have chosen the finovate platform for launching new companies or technology. The best demo sessions also have a chance to win the Best Of Show award.

Finovate sessions are well-curated to create the maximum impact and offer high returns to those participating in the event. Connect with top innovators and regulators who have shaped several financial services globally over drinks, lunches, demo breaks, and more.

To know more, please visit https://ibn.fm/BTFPR

• The recent COP28 Conference laid out the world’s plans to both, phase out fossil fuels as well as triple ongoing investment in renewable energy technologies
• The dramatic increase in renewable energy demand, particularly amongst households, is a trend which Turbo Energy is seeking to capitalize on
• The launch of the company’s ‘SunBox’ home system provides end users with the ability to harness and make use of solar energy through a single, standalone product
• Turbo Energy recently announced the start of a distribution partnership with Solar360, a division of Spanish telecom giant, Movistar

Speaking at the United Nation’s Climate Change Conference (COP28) in Dubai last year, COP28 President Sultan al-Jaber revealed the ‘Global Stocktake’, an agreement which heralded the “beginning of the end” of the fossil fuel era by laying the ground for a swift, just and equitable transition, underpinned by deep emission cuts and scaled-up finance (https://ibn.fm/ddVP3). Alongside the landmark statement, the agreement also stipulated the tripling of new investments in renewable energy in coming years. Renewable energy sources like wind and solar have seen their cost structures decline dramatically in recent years, arriving at cost parity with fossil-fuel powered energy sources in several global markets. The decline in renewable energy costs coupled with the exponential rise in fossil fuel prices have led to a dramatic increase in renewable energy demand, a phenomenon which the likes of Turbo Energy (NASDAQ: TURB), a designer, developer and manufacturer of photovoltaic energy generation, management, and storage equipment, have sought to capitalize on.

Despite their higher upfront costs – in early 2023, it cost an average of $18,000 to install a 6kW grid-tied solar system, solar energy home systems have long posed an attractive investment proposition for homeowners. Solar panels have a usable lifespan of 25 years on longer; homeowners who install solar panels tend to break even within six to ten years due to utility bill savings (https://ibn.fm/GjAh4) providing for an attractive return on investment. Whilst the investment case for solar panels has been generally well-understood, recent, volatile moves in hydrocarbon prices have served as a further incentive for homeowners seeking to shift towards renewable energy sources.

Turbo Energy has looked to capitalize on the growing transition towards renewable energy and sustainable residential energy supplies though its revolutionary ‘SunBox Home’ energy storage solution. The company’s ‘SunBox Home’ system encompasses an all-in-one AI-powered energy storage solution, designed to assist households in managing their power consumption. Directly linked to a household’s solar panel generation unit, the SunBox system allows users to choose between settings including ‘maximum consumption’ or ‘maximum savings’, conserve a portion of its energy reserves in the event of unexpected electricity blackouts or rather, sell excess power back onto the grid.  The groundbreaking energy storage system additionally boasts the capacity to track weather forecasts, thus ensuring its batteries are fully charged in the event of a storm (https://ibn.fm/RY6SG).

Moreover and in a nod to the technology’s growing popularity – particularly in Spain where the installed capacity of household solar energy systems increased by a remarkable 2.5 gigawatts in 2022 alone (i.e. nearly half of the cumulative 5.2 gigawatts installed to date), Turbo Energy recently announced that it had begun marketing its household solar energy systems in partnership with Solar360, the energy division of Movistar – Latin America’s largest telecommunication company and one of the world’s 500 most valuable companies (https://ibn.fm/fwhtn). The deal, which will see Turbo Energy dramatically build upon its distribution footprint, will enable Spanish households to capture and make use of solar energy power within their homes without the need to apply for special permits or recruit professional installation support.

“It is very gratifying for us to see that Movistar, a leading home-services brand, is committed to Turbo Energy,” said Mariano Soria, CEO of Turbo Energy. “It encourages us to continue researching and developing products that contribute to the sustainable reduction of energy costs for thousands of homes and businesses.”

For more information, visit the company’s website at www.Turbo-e.com.

NOTE TO INVESTORS: The latest news and updates relating to TURB are available in the company’s newsroom at https://ibn.fm/TURB

• During the first three quarters of 2023, 32.23 million data breaches were exposed worldwide
• Sekur CEO Alain Ghiai’s “Weekly Hack” segment explores preventative measures to lessen the likelihood of an attack or data leak
• The company’s Swiss-hosted solutions offer individuals, businesses, and governments options for secure and private communications and internet security

During the pandemic, data breaches worldwide spiraled out of control, with 284.34 million breaches in data recorded. Since then, the highest recorded data breach numbers came during the first three quarters of 2023, with 32.25 million data breaches exposed worldwide (https://ibn.fm/ZXWWU). This week’s “Sekur Privacy & Sekur Security – The Weekly Hack” segment with TV host and multi-media journalist Ana Berry and internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO of Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications, explores preventative measures that can lessen the likelihood of an attack or data leak.

Mr. Ghiai recommends never using free WiFi services and not using free Big Tech emails and messaging services when transmitting secure and private information. He also recommends using safe and encrypted VPN services to ensure private data isn’t hijacked (https://ibn.fm/gV5Zi). To help users with a secure means of communicating and transmitting secure data – Sekur’s suite of cybersecurity and internet privacy solutions provides users with the highest level of security with the company’s wholly owned and managed Swiss-hosted solutions.

Sekur’s suite of services includes:

SekurMail(R) with SekurSend/SekurReply is an encrypted email service offering a private, safe, and powerful tool to communicate with everyone within or outside the Sekur ecosystem. SekurMail protects personal information and communications from being accessed by unauthorized parties.

SekurVPN(R) creates a secure, encrypted connection between client’s devices and the internet, giving safe access to the web by routing connections through the company’s wholly-owned Swiss servers. All data sent and received is hidden from prying eyes, including the client’s Internet Service Provider, potential hackers, government surveillance agencies, and more.

SekurMessenger(R) is a Swiss-hosted private and secure messaging communications app that provides secure and private chat, self-deleting chat, voice recording, and file transfer via any mobile device, tablet, or desktop computer. The app is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged.

Sekur has chosen Switzerland to locate its data storage because of its neutrality, independence, strong privacy laws, long-standing political stability, and excellent international relations. All data is stored in bank-approved, state-of-the-art ISO-certified data centers – with data protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offers some of the strongest privacy protection in the world for both individuals and organizations.

Sekur makes its services available to individuals, businesses, and governments worldwide. None of the data protected by the company is ever sold to third-party companies or tracked. (The suite is available as a subscription service, and during the “Weekly Hack” segment, Mr. Ghiai offers a 15% savings good for five years with PROMO CODE: PRIVACY).

For more information, visit the company’s website at www.SekurPrivateData.com, or the company’s product site at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

• Lexaria, a global innovator in drug delivery platforms, has laid down its GLP-1 human and animal studies roadmap for the 2024 calendar year
• This builds on the success of its human pilot study, which marked a successful undertaking for exploring its patented DehydraTECH(TM) technology for the improved delivery of the GLP-1 drug semaglutide, available commercially in the branded product Rybelsus(R)
• The company’s chronic dosing animal study and its second human pilot study will commence in Spring and run for 12 weeks. The third human pilot study will start in May or June
• These studies will evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced five additional studies that aim to support commercial partnering for glucagon-like peptide-1 (“GLP-1”) agonists with its patented DehydraTECH(TM) technology. This follows the update on the final results from its human pilot study in what marked a successful undertaking for exploring DehydraTECH for the improved delivery of the GLP-1 drug Rybelsus(R), reduced side effects, enhanced weight loss, and improved health outcomes, per recent Zacks report (https://ibn.fm/CzDhY).

Of note from the human pilot study was the sustained higher levels of semaglutide in blood using DehydraTECH technology, even 24 hours after a single dose.  DehydraTECH processing technology enhancements also achieved better blood glucose control, faster peak drug delivery and reduced side effects.

The 2024 GLP-1 study program will aim to characterize the pharmacokinetics of DehydraTECH processing technology enhancements while also exploring the commercial applicability of DehydraTECH-formulated versions of semaglutide, liraglutide, and tirzepatide. Lexaria plans to embark on one animal, three human studies, and long-term stability testing on DehydraTECH compositions of GLP-1 agonists. All of these proposed studies will depend upon sufficient funding, and all human studies will be investigator initiated non-registrational studies, and will require certain approvals before they commence.

Lexaria’s chronic dosing animal study will advance 12 arms with 8-10 obese rats per arm. It is scheduled to commence in Spring 2024. It will run for 12 weeks, with the primary objective of evaluating weight loss, pharmacokinetics, and blood sugar control over the duration of the study. Once completed, a full analysis will be performed, and results will be shared with stakeholders. This study will use DehydraTECH formulations of semaglutide and liraglutide alone and with DehydraTECH-CBD.

A second human pilot study will begin in Spring 2024, with the third starting in May or June 2024. The latter will enroll up to eight healthy human volunteers and evaluate DehydraTECH’s effectiveness in combination with a dual-action GLP-1 agonist and a glucose-dependent insulintropic peptide (“GIP”) drug absent in the SNAC formulation. It will build on the second human clinical study, whose primary objective would be to evaluate tolerability, side effects, pharmacokinetics, and blood sugar control.

For the 2024 calendar year, Lexaria also plans to evaluate the chemical and microbiological purity and stability of select DehydraTECH compositions over 6-12 months. This long term stability testing is crucial if oral variants of GLP-1 drugs are to be seriously considered as replacements for currently injectable versions of these drugs. All the studies lined up for the year will support this objective, and the company’s management is optimistic that it will be realized.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

In a recent episode of the ‘Bell2Bell Podcast’ hosted by Stuart Smith, Astiva Health was spotlighted as a significant player in the Medicare Advantage Prescription Drug (“MAPD”) sector. The episode featured an exclusive interview with Astiva Health’s Co-Founder and CEO, Dr. Tri Nguyen, a renowned expert in internal medicine and cardiology.

Listen to the full interview to hear Dr. Nguyen discuss Astiva Health’s journey since its inception in 2020 and its expansion plans. He shared insightful details about the company’s expansion to Los Angeles, San Bernardino, and Riverside from January 1, 2024, marking a pivotal phase in transforming healthcare delivery.

One key highlight from the podcast was Astiva Health surpassing the 10,000-member milestone. Dr. Nguyen attributed this success to the company’s philosophy, which emphasizes loving life at any age. This principle is central to Astiva’s commitment to ensuring life is lived with fulfillment.

Astiva Health’s approach goes beyond providing medical care and prescription drugs. As Dr. Nguyen explains in the interview, it includes offering rich supplemental benefits to engage enrollees in a meaningful, healthy life. He emphasized the importance of patient involvement in successful medical outcomes, a cornerstone of Astiva Health’s strategy.

Looking forward in the podcast discussion, Dr. Nguyen outlined Astiva Health’s operational goals for 2024, including an ambitious plan to list its common shares on the NASDAQ Global Select. This strategic move aligns with Astiva Health’s broader goals of expanding its impact.

The vision for Astiva Health, as Dr. Nguyen shares on the Bell2Bell Podcast, is to redefine healthcare accessibility and quality. He envisions Astiva Health as a comprehensive healthcare provider for all who can benefit from it, highlighting potential growth and service expansion.

The interview concluded with Dr. Nguyen thanking Stuart Smith for the opportunity to discuss Astiva Health’s journey and future plans. For more information about Astiva Health, listeners are directed to the company’s website.

Catch the full depth of this engaging conversation with Dr. Tri Nguyen on the Bell2Bell Podcast, offering listeners a deeper understanding of Astiva Health’s mission, achievements, and future aspirations in the healthcare sector.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

• The U.S. Securities and Exchange Commission recently won a judgment that furthers its efforts to bring crypto-based transactions under its purview, seen as enhancing the sense of security needed for larger public acceptance of the digital sector
• Many investors have taken an interest in the heady accomplishments of the digital asset sector but have been reluctant to get involved due to uncertainties or a simple wariness of having to become tech savvy
• Utah-based Diamond Lake Minerals Inc. is positioning itself as a bridge-builder that helps traditional investors step effortlessly into the digital asset sector with expectations of government-regulated stability
• DLMI’s model presents digital security token offerings as an integral element of its numerous industry-agnostic subsidiaries that have their own investor appeal

Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is helping investors navigate the perceived complexities of adding digital assets to their portfolios by providing a more safe and simple gateway. Security tokens, registered with the U.S. Securities and Exchange Commission (“SEC”), are embedded in Diamond Lake’s subsidiaries to form a traditional investment opportunity that is also imbued with digital asset elements.

A recent federal court ruling sustaining the SEC’s continued efforts to bring more crypto-based transactions under its purview, further demonstrates the importance of the legal landscape surrounding the regulation of digital assets (https://ibn.fm/tm7UZ). DLMI’s determination to use only SEC-registered security tokens as the digital offering of its industry-agnostic subsidiaries reflects the company’s emphasis on compliance with securities laws.

“The current philosophy and model is not tokenizing the shares, but it’s actually tokenizing business units within our subsidiaries. So there’ll be an attachment to some revenue-generating mechanism within the subsidiaries that we would go out to the public markets with … and offer participation in those businesses to a global audience,” DLMI CEO Brian J. Esposito said during a recent interview with the Cryptonized webcast (https://ibn.fm/L1QHd). Diamond Lake is making its security token offerings (“STOs”) available through the SEC-regulated security token exchange INX (https://ibn.fm/e9X5l).

“As a supporter and believer and shareholder in DLMI, I want this to be a security that I never want to get rid of … and it’s also a security or a security token that I hold that pays me and my shareholders a dividend or a yield or a revenue share of some sort,” Esposito said. “In theory, you should have a Berkshire-Hathaway class A stock on your hands. … With the idea of what does the future of capitalization look like and what does the future of a global investor look like.”

Esposito said the company is trying to position its offerings as a “missing link” that will bring traditional investors over to the digital environment as they become involved with the company’s subsidiaries, which include sectors ranging from entertainment to healthcare. “You’ve got to future-proof anything. You’ve got to adapt or die. If you don’t, you die — that’s the reality,” he said.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• A recent study shows that medical cannabis treatment may be associated with improvements in health-related quality of life
• Study data indicated that chronic noncancer pain was the most common indication for treatment, followed by cancer pain, insomnia and anxiety
• MedCana is building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world

Cannabis, long shrouded in controversy, is stepping into the limelight of scientific inquiry, revealing a complex tapestry of potential benefits. Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), a global infrastructure and holding company in the cannabis industry, is paying close attention to growing data showing the power of the natural substance.

One recent study, conducted by postdoctoral research fellow Thomas Arkell, a PhD at Swinburne University of Technology in Melbourne, Australia, suggests that medical cannabis treatment may be associated with improvements in health-related quality of life among patients with a range of health conditions (https://ibn.fm/DUJBL). The results of the study were published earlier this year by JAMA Network Open.

“The use of cannabis as a medicine is becoming increasingly prevalent,” the report stated. “Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical evidence incorporating patient-reported outcomes may help determine safety and efficacy.” According to the report, this case series study was conducted at a network of specialist medical clinics and included patients who received treatment for any indication between December 2018 and May 2022.

Results of the study, which included 3,148 patients, were noteworthy. Study data indicated that chronic noncancer pain was the most common indication for treatment, followed by cancer pain, insomnia and anxiety. “After commencing treatment with medical cannabis, patients reported significant improvements relative to baseline on all eight domains of the SF-36 (the 36-item short form health survey questionnaire), and these improvements were mostly sustained over time,” JAMA reported. After controlling for potential confounders in a regression model, treatment with medical cannabis indicated marked improvement.

This is just one of innumerable studies focused on cannabis. Recently, NORML, a nonprofit organization that represents the interests of the tens of millions of Americans who use marijuana responsibly, reported that there are more than 36,000 peer-reviewed papers in the scientific literature referencing the cannabis plant and its cannabinoids, according to a keyword search on the search engine PubMed Central, the U.S. government repository for peer-reviewed scientific research (https://ibn.fm/cj9nJ).

“In recent years, this volume of research has grown exponentially, with more than 20,000 papers published just in the past decade,” the report noted. “Much of this more recent research has been dedicated to exploring and verifying cannabis’ therapeutic activities in various patient populations – including in FDA-approved gold-standard clinical trials. A summary of this clinical trial data concluded: ‘Evidence is accumulating that cannabinoids may be useful medicine for certain indications. . . . The classification of marijuana as a Schedule I drug as well as the continuing controversy as to whether or not cannabis is of medical value are obstacles to medical progress in this area. Based on evidence currently available, the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.’”

This is positive news for MedCana, which has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. In addition, the company recently rounded out its portfolio of holdings with the acquisition of an irrigation and greenhouse technology company.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://ibn.fm/SFWJ

• GEMXX recently presented at the Sequire Investor Summit 2024, showing how their dgreater control of the mining value chain represents a significant competitive advantage
• The company shared its knowledge and expertise in all stages of its production, including gold mining, gemstone (Ammolite) production, jewelry manufacturing, and global distribution
• GEMXX continues to control all stages of its production, which enables it to manage its mining value chain and support its mine-to-market strategy
• According to a McKinsey report, mining companies that manage their value chain well can establish a significant source of competitive advantage and value creation

GEMXX (OTC: GEMZ), a company that focuses on producing gold, gemstone, and jewelry from its own land resources, production facilities, and operating assets, recently presented at the Sequire Investor Summit 2024 held in Puerto Rico (https://ibn.fm/V33Tw). In the presentation, the company shared its mine-to-market capabilities, covering all stages of its production, including gold mining, gemstone (Ammolite) production, jewelry manufacturing, and global distribution.

With the company controlling all of these stages as part of its strategy to support its mine-to-market business model, GEMXX has established a significant source of competitive advantage and value creation. As a McKinsey report details: “The mining value chain – which includes everything from extracting raw material to delivering products to consumers – is the backbone of the industry. Companies that manage their value chain well can establish a significant source of competitive advantage and value creation. By contrast, those that neglect their value chain are likely to encounter bottlenecks and constraints that will limit shipped throughput and risk yield,” (https://ibn.fm/tfkUg).

On the mining front, GEMXX specializes in the mining of gold, still the world’s most sought-after commodity, and Ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta. “Currently, the company has $600 million in proven Ammolite reserves and $200 million in gold reserves,” the company says in a video published on its website (https://ibn.fm/XI8ME).

According to GEMXX, the value of Ammolite has increased by more than 300% over the past 20 years, with the demand for Ammolite gemstone products equally rising in tandem. To meet this growing demand and capitalize on the increase in value, the company, in November 2023, announced its plan to open an Ammolite mine on the south block, one of the three separate blocks in Southern Alberta, Canada, where its Ammolite resources are located. This move is expected to help GEMXX expand its existing Ammolite gemstone production (https://ibn.fm/Yocqd).

Similarly, the company has made substantial steps to increase its proven gold reserves. Last year, GEMXX completed the acquisition of a 50% equity stake in a Canadian exploration company, Crazy Horse Mining Inc., which owns a 100% interest in two gold projects in British Columbia, Canada: Snow Creek and Rosella Creek (https://ibn.fm/R57YR). GEMXX also signed a letter of intent to acquire a 50% interest in the proven Yukon Gold Project with an estimated 4 million ounces of gold (https://ibn.fm/czyVa).

Further up the value chain, GEMXX is a renowned manufacturer of Ammolite jewelry, a status that led to an exclusive Ammolite supply agreement with Canadian Ammolite Gems by Kenneth Bradley (https://ibn.fm/anHHJ). Bradley praised the company’s quality work, saying, “It is my opinion that GEMXX supplies the finest Ammolite in the world, and that is why I have selected them as the exclusive supplier for my Ammolite jewelry.”

GEMXX also has a shopping channel division that is preparing to supply $5.5 million worth of Ammolite jewelry through 2024 as part of the company’s expansion plans, according to CEO Jay Maull. As a result of the division’s operations, Maull explained, “GEMXX Ammolite products will now have an expanded on-air presence in the United States, Canada, and Australia.”

The company continues to control each stage of its production, enabling it to manage its mining value chain. This strategy, McKinsey analysts say, can establish a significant source of competitive advantage and value creation, particularly for shareholders.

Those interested in participating through Reg A financing are encouraged to visit the company’s investor page (https://ibn.fm/718tT) or contact company officials for more information (ir@gemxx.com – 702-930-1815).

For more information, visit the company’s website at www.GEMXX.com/investors.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ